baber/WOPTO huggingface dataset:
Patent PT-629482-E (PT)
Inventor: LIEVRE PATRICK LE
IPC: B60J10/02
Filed: 1994-06-16
Abstract: The invention relates to a device for obtaining a glazing pane surrounded, over at least part of its periphery, by an overmoulded plastic. This device comprises an injection head, a mould cavity, an injection gate (threshold) (8) and at least one mould part in the wall of which is provided a runner (channel) (13, 17) comprising the said injection gate. The runner comprises two parts, a part (13) located away from the parting line and a part (17) located in the parting line. <IMAGE>
Patent PT-702085-E (PT)
Inventor: CONZELMANN KARL KLAUS
IPC: A61K39/12
Filed: 1995-07-14
Abstract: The present invention provides the generation of infectious replicating non-segmented negative-stranded RNA virus, entirely from cloned cDNA. <??>This process offers the possibility to introduce mutations into the virus genome by means of recombinant DNA techniques.
Patent PT-755604-E (PT)
Inventor: ROSENGREN JURGEN FRITZ
IPC: H04N1/00
Filed: 1995-04-10
Abstract: The invention relates to a method and arrangement for deriving an ancillary signal from a compressed digital video signal (e.g. MPEG). The DC coefficients of autonomously encoded pictures (I-pictures) are selected from the compressed signal. The ancillary signal thus obtained can be used for display in a (multi-) picture-in-picture television receiver. A decoder for decoding such an ancillary signal is considerably simpler and less expensive than a full-spec MPEG decoder.
Patent PT-772610-E (PT)
Inventor: FLOCKERZI DIETER
IPC: A61P25/28
Filed: 1995-07-19
Abstract: PCT No. PCT/EP95/02841 Sec. 371 Date Apr. 15, 1997 Sec. 102(e) Date Apr. 15, 1997 PCT Filed Jul. 19, 1995 PCT Pub. No. WO96/03399 PCT Pub. Date Feb. 8, 1996The invention concerns componuds of formula (I), in which R1, R2, R3 and R4 have the meanings given in the description. The compounds are novel, effective PDE-inhibitors.
Patent PT-799210-E (PT)
Inventor: ASHWORTH PHILIP ANTHONY
IPC: A61P31/12
Filed: 1995-12-22
Abstract: PCT No. PCT/GB95/03029 Sec. 371 Date Aug. 29, 1997 Sec. 102(e) Date Aug. 29, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/20180 PCT Pub. Date Jul. 4, 1996A piperazinedione of general formula (I): wherein R1 is selected from hydrogen; a group of formula -(NH)t-COR3 wherein t is 0 or 1 and R3 is an organic substituent as defined herein; a group of formula (D):  and a group of formula (E): and the pharmaceutically acceptable salts thereof are useful as modulators of multi-drug resistance.
Patent PT-848537-E (PT)
Inventor: ERGEZINGER SIEGFRIED
IPC: G06Q20/00
Filed: 1996-12-12
Abstract: The system allows the user of a mobile telephone to uses a special call line number to access the system when the user's stored credit limit has been used up. A personal identification number is entered together with a credit card into a networked terminal and a menu is displayed that allows the required amount of credit to be selected. When the sequence of checks have been completed the transaction is allowed.
Patent PT-765323-E (PT)
Inventor: ORTIZ JOSE A
IPC: A61P25/20
Filed: 1996-04-11
Abstract: PCT No. PCT/EP96/01551 Sec. 371 Date Mar. 14, 1997 Sec. 102(e) Date Mar. 14, 1997 PCT Filed Apr. 11, 1996 PCT Pub. No. WO96/32389 PCT Pub. Date Oct. 17, 1996The present invention relates to 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives having the formula (I):    <IMAGE>  (I)  wherein R is hydrogen or alkyl having 1 to 4 carbon atoms optionally substituted by hydroxyl, as well as their pharmaceutically acceptable addition salts, which are useful in the treatment of psychosis, schizophrenia and anxiety.
Patent PT-833638-E (PT)
Inventor: CARTER DONALD B
IPC: A61P25/14
Filed: 1996-06-03
Abstract: The imidazo[1,5-a]quinolines (I) are useful in treating neurological diseases/conditions or chronic neurodegenerative diseases/conditions.
Patent PT-941244-E (PT)
Title: Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide and a method of detecting auto-immune antibodies
Inventor: VENROOIJ WALTHERUS JACOBUS WILHELMUS VAN
IPC: C07K16/18
Filed: 1997-11-14
Abstract: The invention relates to a peptide derived from an antigen recognized by autoantibodies, which peptide is reactive with autoimmune antibodies from a patient suffering from rheumatoid arthritis. The peptide according to the invention possesses a modified arginine residue. The invention also relates to antibodies against the peptide and a method of detecting autoimmune antibodies.
Patent PT-901595-E (PT)
Inventor: LORAN HAIM
IPC: F15B1/22
Filed: 1997-06-04
Abstract: An improved hydraulic accumulator is introduced wherein a valve mechanism is used to seal a hydraulic fluid before the pressure charged piston reaches the end of the accumulator to minimize the loss of compressed gas by eliminating the pressure differential when the piston is fully extended, thereby prolonging the fatigue life of the accumulator vessel. Reduction of the pressure loading on the vessel will also prolong the life of the piston seals and metal bellows effectively extending the accumulator life and effectively allowing design for weight reduction and preservation of the integrity of the complete hydraulic or pneumatic system.
Patent PT-860638-E (PT)
Inventor: KLEISER KLAUS
IPC: F16L1/028
Filed: 1998-02-18
Abstract: The device comprises a drill bar (14) with a retractable head (16) and central holding shaft (18) aligned with the drill bar and to which a counter pressure plate (32) is fixed. A number of centering devices (22) extend radially outwards from the holding shaft (18). The holding shaft comprises different individual segments (18a,18b), which are connectable to one another by threads (20) or pin connections. The outer diameter of the retractable head (16) is equal to the outer diameter of the pipe (24) to be retracted or larger than it. On one individual segment of the holding shaft centering devices (22) are located in at least two positions axially spaced apart. Each centering device comprises a number of regulatable hydraulic cylinders which extend radially outwards from the holding shaft and can be regulated individually. The centering devices incorporate a number of leaf springs extending radially outwards from the holding shaft and having a curved shape.
Patent PT-1002741-E (PT)
Inventor: LOHREY WILHELM
IPC: B65D81/00
Filed: 1998-06-10
Abstract: The thread(19) of the teabag is located inside the chamber containing the tea with its free first end(20) permanently connected to the transversely extending hot seal of the teabag's bottom end(9), and with its second end(21) passing through the transversely extending hot seal of the top end(10) and withdrawable from the chamber. Outside the chamber the thread is connected to the tag(22), especially through hot sealing, with the tag lightly attached to the teabag. An Independent claim is included for a procedure for the manufacture of a single-chamber teabag which includes the aforesaid positioning and attachment of the thread in the teabag.
Patent PT-1060241-E (PT)
Title: Preparation of cells for production of biologicals
Inventor: BRANDS RUDI
IPC: C12N5/071
Filed: 1998-12-17
Abstract: Method for the production of biologicals, wherein cells are cultured up till a desired cell volume of a preproduction batch, where after in a repeated discontinuous process:a) part of the cells of the preproduction batch is used for the preparation of at least one production batch, andb) the remaining part of the cells of the preproduction batch is used as a seed for the preparation of at least one subsequent preproduction batch,and the cells of the production batches are used for the production of the biologicals.
Patent PT-1072177-E (PT)
Title: Apparatus for the redistribution of acoustic energy
Inventor: LACARRUBBA EMANUEL
IPC: G10K11/20
Filed: 1999-04-13
Abstract: An apparatus for the redistribution of acoustic energy is provided which comprises a lens having a reflective surface defined by the surface of revolution R1 of an elliptical arc A1 rotated about a line L through an angle  alpha 1 and the surface of revolution R2 of an elliptical arc A2 rotated about the line L through an angle  alpha 2. Each elliptical arc A1 and A2 constitutes a portion of an ellipse E1 or E2 having a focal point located at a point F1 on line L, and shares an end point P which lies on the reflective surface and the line L. The angle  alpha 1 is chosen such that the surface of revolution R1 is convex with respect to an adjoining surface S1 and the angle  alpha 2 is chosen such that the surface of revolution R2 is concave with respect to the adjoining surface S1.
Patent IE-830224-L (IE)
Title: Terminating an electrical conductor to an electrical¹connector
IPC: H01R43/00
Filed: 1983-02-04
Abstract: A method of, and apparatus for terminating an electrical conductor to an electrical connector. …<??>An insulating housing of an electrical connector (4) and a cover (16) for the housing, are to be mated to terminate an electrical conductor (C) inserted between the connector (4) and the cover (16), to an electrical terminal in the connector (4). To this end the leading connector (4) of a row of connectors (4) is positioned on an anvil (63), the conductor (C) is inserted between the cover (16) and the connector (4) and a terminating punch is applied to the cover (16) to mate it with the connector housing. The connectors (4) of the row are detachably joined together in the form of a strip (2) and a column of covers (16) is also fed in the direction of the anvil (63) to position the leading cover (16) of the column between the punch (64) and the anvil (63). When the housing of the leading connector has been mated with the leading cover (16), the leading connector (4) and the next following connector (4) of the strip (2) are relatively displaced to detach the leading connector from the strip. 
[EP0087209A2]
Patent IE-34979-L (IE)
Title: Enzyme-polymer-complexes
IPC: C11D3/386
Filed: 1971-03-03
Abstract: 1353317 Enzyme-polymer complexes KONINKLIJKE NEDERLANDSCHE GIST-EN SPIRITUSFABRIEK NV 19 April 1971 [3 March 1970] 10240/70 Heading C3H [Also in Division C5] Complexes which are useful in formulating washing compositions comprise an enzyme, in particular a proteolytic enzyme, complexed with an aqueous alkali-soluble polymer having a straight or branched carbon chain with carboxylic groups attached thereto and which may also contain other substituents, e.g. substituted or unsubstituted hydrocarbon groups or which is interrupted by hetero atoms, the polymer having a M.Wt. of at least 10,000 and containing no covalent bonds between the enzyme and polymer. Suitable polymers are acrylic and methacrylic acid polymers and copolymers thereof and of maleic acid with styrene, ethylene or methyl vinyl ether. Enzymes referred to include proteases, lipases, and amylases including those produced by various bacilli. The complexes may be made by contacting the enzyme with a solution of the polymer and precipitating the complex, e.g. by addition of an organic non- solvent therefor such as acetone or ethanol, or by adding a metal ion, e.g. Al<SP>+++</SP>, Fe<SP>+++</SP>, Cr<SP>++</SP><SP>+</SP> or Zr<SP>+++</SP>. The use of such metal ions gives rise to modified complexes in which the metal is present.
[GB1353317A]
Patent IE-850452-L (IE)
Title: Crf analogs
IPC: C07K1/02
Filed: 1985-02-22
Abstract: Agonists of rCRF and oCRF are disclosed that can be administered to achieve a substantial elevation of ACTH. ß-endorphin, ß-lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or a lowering of blood pressure over an extended period of time. One agonist which has been found to be particularly potent is: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH<sub>2</sub>. In the agonists, one or more of the first five N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and cr by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain. Similar peptides which function as CRF antagonists are ceated by deleting the first 7, 8 or 9 N-terminal residues. These analogs or pharmaceuncally or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier can be administered to mammals, including humans The agonists may also be used as stimulants to elevate mood and improve memory and teaming, as well as diagnostically. The antagonists can be used to lower stress.
Patent IE-850655-L (IE)
Title: Ceramic materials and methods for making them
IPC: C22C29/12
Filed: 1985-03-14
Abstract: Novel self-supporting oxide ceramic materials are produced by the reaction of a molten metal with a vapor phase oxidizing environment using a novel oxidation mechanism. The process is practiced by creating conditions under which the molten is drawn into and through the oxide reaction product to cause continued growth of oxide at the oxideatmosphere interface. Under the special conditions of the process invention, molten metal is transported along certain of the intersections of the oxide crystallites by virtue of a preferred wetting phenomenon, such that interconnected channels of the liquid metal are formed where grain boundaries of relatively high surface energy would otherwise occur in the oxide. The resulting novel ceramic product consists of an oxide phase which is interconnected largely through relatively low energy grain boundaries and a metal phase (or porosity in place of the metal phase) also at least partially interconnected.
[EP0155831A2]
Patent IE-32884-L (IE)
Title: Amides
IPC: C08G59/54
Filed: 1969-06-03
Abstract: 1,235,805. Amine-amide condensation products. INVENTA FUR FORSCHUNG UND PATENTVERWERTUNG A.G. 5 June, 1969 [5 June, 1968], No. 28481/69. Heading C2C. [Also in Division C3] Compounds of the general formula (where R 1 is a lower alkyl group of from one to four carbon atoms, R 2 is a divalent aliphatic, cycloaliphatic or aralkylene radical which may contain ether, thioether or secondary or tertiary amino linkages and n is from 2-12) may be prepared by reacting at least two molar proportions of an amine NH 2 R 2 .NH 2 with one molar proportion of an N-alkylaminocarboxylic acid R 1 NH.(CH 2 ) n .COOH at 170-250 C. in an inert atmosphere, and thereafter distilling off excess amine under reduced pressure. Specified amines include 1,2-bis-(3-aminopropoxy) ethane, 1,3- and 1,4 - bis - (3 - aminopropoxy) butane, 1,6- bis - (3 - aminopropoxy) hexane, 4,4<SP>1</SP> - diaminodibutyl ether, bis-(2-aminoethyl) sulphide, N,N- bis- (3 - aminopropyl) methylamine, triethylene tetramine, 1,6 - hexamethylene diamine, 3,3,5- trimethyl - 5 - aminomethyl - cyclohexylamine, o-, in-, and p-xylylene diamines and 2,2,4-trimethyl hexamethylenediamine, and specified acids include N-methyl-, ethyl-, propyl-, isopropyl, and butyl-derivatives of co-aminocaproic, -capric, -caprylic, -undecanoic and -lauric acids. The condensates are curing agents for epoxy resins (see Division C3).
[GB1235805A]
Patent IE-900993-L (IE)
Title: Process for the insolubilization and agglomeration of wastes¹from smoke purification
IPC: B09B3/00
Filed: 1990-03-16
Abstract: Incinerator fly ash (FA) is mixed with small quantities of water of between 10 % and 35 % of its weight, the product being then compacted and extruded. In practice it is advantageous to add small quantities of lime to the water to have a pH of 7.4 to 11.6, it being possible for this lime to be combined with a product containing silica and/or alumina. Solid compositions which are practically insoluble in water and nonpolluting are obtained.
[EP0389328A1]
Patent FI-803757-L (FI)
Inventor: KUNG PATRICK CHUNG-SHU
IPC: C12P1/00
Filed: 1980-12-03
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 95% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF, mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent FI-822322-L (FI)
Inventor: BECKER RHEINHOLD
IPC: A22C11/02
Filed: 1982-06-29
Abstract: A device for deshirring, smoothing and braking a shirred tubular casing during stuffing of the casing with a fluid mass flowing under pressure from the stuffing horn of a stuffing machine into the tubular casing. The device comprises an annular body having a central opening releasably securable to the stuffing horn, said annular body having recesses on its outer surface extending parallel to its longitudinal axis. The recesses have a substantially U-shaped, V-shaped or rectangular cross-sectional configuration or end view configuration. The configuration of the braking and smoothing elements corresponds to that of the recesses in the surface of the annular body. The braking elements and/or the annular body are displaceable relative to each other either parallel to the longitudinal axis of the stuffing horn or the elements are displaceable perpendicular to the longitudinal axis of the stuffing horn so that the braking elements can be extended into the recesses or spaced away from the recesses. An apparatus comprising a device of the aforementioned type is also disclosed.
Patent IE-801461-L (IE)
Title: Window frame
IPC: E06B3/12
Filed: 1980-07-14
Abstract: A window or glazed door comprises a wing frame 1 surrounding a glass panel 3 and a main frame 2 each comprising aluminum box- sectioned or hollow members 4, 5 which project inwards of the room or the like beyond the panel 3, as at 4a and 5a, and are there overlaid by or enclosed by hollow or box-sectioned plastics members 6, 7 which carry seals 12, 13 sealing off a hollow space 14 between the wing and main frames 1, 2. <IMAGE>
[GB2055937A]
Patent IE-841487-L (IE)
Title: Benzocyclobutenes
IPC: C07C62/38
Filed: 1984-06-14
Abstract: Substituted benzophenones of the formula <IMAGE> (I) in which Ph represents unsubstituted or substituted phenyl and R represents free, esterified or amidated carboxy, have anti-inflammatory and/or analgesic properties and can be used as active ingredients in medicaments. They are manufactured, for example, as follows: a compound or a mixture of compounds of the formula <IMAGE> (II) in which X1 and X2 together represent a group of the formula -C(=O)-O that is bonded via the carbonyl group to the radical Ph and X3 represents hydrogen, or one of the radicals X1 and X3 represents a group of the formula -C(=O)-Z, the other represents hydrogen and X2 represents a group R'O- in which R' represents hydrogen or a hydroxy-protecting group, is subjected to acid treatment and the primary product is decomposed solvolytically.
[US4523030A]
Patent IE-841631-L (IE)
Title: Disposable urinary and fecal waste containment product.
IPC: A61F5/44
Filed: 1984-06-27
Abstract: A disposable urinary and fecal waste containment product (10) is described, suitable for active adults. The product has a high liquid impact capacity, high liquid retention, contains fecal waste without leakage and allows the skin of the wearer to remain dry. The product has a liquid-impermeable substantially flexible shell (12) with a front portion (16) containing a superstructure associated with an absorbent medium and a rear portion (14) with a superstructure of three-dimensional characteristics with sufficient friction to prevent movement of fecal matter laterally.
[EP0140471A1]
Patent IE-45673-L (IE)
Title: Camera system for forming a scrambled image
IPC: G03B35/00
Filed: 1977-08-31
Abstract: An improved camera and process of coding images and a product produced thereby is described in which an image of graphics is scrambled by operation of a pseudoscopic camera. The graphics and focal plane-type shutter are moved simultaneously relative to an objective lens and a graticule so as to produce an image of the graphics-which will appear inchoate to ordinary vision. The image can be unscrambled by viewing the same through a graticule of the same nature as that used in the scrambling process.
[CA1090640A]
Patent IE-902055-L (IE)
Title: Reagents for rapid peptide synthesis
IPC: C07D333/64
Filed: 1990-06-08
Abstract: This invention relates to compounds of the formula: <CHEM>  wherein R is an electron withdrawing group;  R1 is H or COZ; X1 and X2 are independently H, lower alkyl, aryl, aryl lower-alkyl or polystyrene or R and X1 taken together with the carbon atoms to which they are attached form a ring containing from 4 to 15 ring carbon atoms and may contain up to 2 heteroatoms, wherein the heteroatoms are O, S, or N; and Z is an amino acid residue, a peptide residue or a leaving group. The compounds of the present invention are adaptable as blocking or protecting groups for an amine composition useful in peptide synthesis. The present invention is also directed to a method of protecting an amino group of an organic molecule during a reaction which modifies a portion of the molecule other than the protected amino group.
Patent IE-802096-L (IE)
Title: Dental saliva ejector
IPC: A61C17/08
Filed: 1980-10-09
Abstract: A dental saliva ejector has a perforated wall provided at each side of a suction opening to prevent tongue and muceous membranes of the patient to be sucked into the opening. The ejector further has a portion intended to rest against a front tooth of the mandible and a securing means intended to contact the chin such that the ejector is held in place by a clamping action between chain and front tooth to prevent pressure against the mouth bottom.
[SE7908449L]
Patent IE-40185-L (IE)
Title: Inhaler
IPC: A61M13/00
Filed: 1974-10-15
Abstract: 1485163 Pocket inhalers ISF SpA 17 Oct 1974 [18 March 1974] 44994/74 Heading AST A device for inhaling medicinal powders provided in a capsule comprises a body portion 21 with a chamber 10 for receiving a capsule, and inhaling passage in a portion 22 leading from the chamber, an elongate recess 9 in the bottom wall of the chamber wherein a capsule rests when the inhaler is not in use, and air intake passages (12, 12') leading from the chamber positioned tangentially so that air drawn in through them when inhaling through the inhaling passage draws the capsule from the recess and imparts a rotary and shaking motion to it; piercing devices are provided to puncture the capsule in the chamber. As shown these are movable push buttons 26 each carrying a set of elongate spikes positioned to act on the capsule when it is lying in the recess 9. The inhaling passage may be a tubular portion 22 joined to the body portion 21 by a pivot (3) to allow the insertion of a capsule, and may be held in the closed position by a latch (4, 5, 6). A grating (1) prevents the capsule from entering the inhaling passage.
[GB1485163A]
Patent IE-872721-L (IE)
Title: Process for preparing penem compounds
IPC: C07D499/00
Filed: 1987-10-12
Abstract: Compounds of the formula I : <CHEM> wherein R1 represents a hydroxy protecting group and R2 represents a carboxy protecting group, useful as intermediates for the preparation of penem antibiotics, are prepared by hydrolysing a compound of the formula II : <CHEM> wherein R1 and R2 are as defined above and R represents an alkyl, alkenyl or phenylalkyl group having from 1 to 18 carbon atoms, by means of an enzyme capable of se lectively hydrolysing the ester group of the 2-substituent thereof. d